E-Medicare Pharma
Online Medicine Pharmacy
0.00$
Order Promacta (Eltrombopag) 50 mg. Trombola (Eltrombopag) 50 mg is a medication primarily used in the treatment of thrombocytopenia (low platelet count) associated with chronic immune thrombocytopenia (ITP) and severe aplastic anemia (SAA). It belongs to a class of drugs known as thrombopoietin receptor agonists, which work by stimulating the production of platelets in the bone marrow. Trombola 50 mg offers a targeted therapy option for patients with thrombocytopenia, helping to increase platelet counts and reduce the risk of bleeding complications.
Trombola (Eltrombopag) 50 mg is indicated for the treatment of:
Trombola (Eltrombopag) 50 mg exerts its pharmacological effects by binding to and activating the thrombopoietin receptor (c-Mpl) on megakaryocytes, stimulating their proliferation and differentiation. This leads to an increase in the production of platelets from the bone marrow, thereby raising platelet counts in the blood.
The recommended dosage of Trombola (Eltrombopag) 50 mg may vary depending on the underlying condition being treated, patient characteristics, and individual response to treatment. Typically, the prescribed dose is 50 mg taken orally once daily, with or without food. Treatment duration may vary based on the response to therapy and the discretion of the treating healthcare provider.
4. Interaction:
Trombola (Eltrombopag) 50 mg may interact with other medications, including:
Patients should inform their healthcare provider about all medications they are taking, including prescription, over-the-counter, and herbal products, to avoid potential interactions.
5. Side Effects:
Common side effects associated with Trombola (Eltrombopag) 50 mg may include:
Patients should report any persistent or severe side effects to their healthcare provider for further evaluation and management.
6. Precautions and Warnings:
Before using Trombola (Eltrombopag) 50 mg, patients should be aware of the following precautions:
7. Overdose Effects:
In case of overdose with Trombola (Eltrombopag) 50 mg, supportive care should be initiated, and symptomatic treatment may be administered as necessary. There is no specific antidote for Eltrombopag overdose, and patients should seek immediate medical attention if overdose is suspected.
Generic Name: | Eltrombopag |
---|---|
Theraputic Category: | Anti-Cancer |
Pack Size: | 28's |
Previous Product
Next Product
Begin your journey to better health . Join now to unlock exclusive tips and insights sent straight to your inbox, empowering you to embrace a healthier lifestyle each and every day.
Online Medicine Pharmacy
+8801929123476 emedicarepharma@gmail.com
65, mymansingh High-way, Dhaka-1230, Bangladesh